249 related articles for article (PubMed ID: 17619759)
1. Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancer.
Russo P; Synder M; Vickers A; Kondagunta V; Motzer R
ScientificWorldJournal; 2007 Feb; 7():768-78. PubMed ID: 17619759
[TBL] [Abstract][Full Text] [Related]
2. Surgical intervention in patients with metastatic renal cancer: metastasectomy and cytoreductive nephrectomy.
Russo P; O'Brien MF
Urol Clin North Am; 2008 Nov; 35(4):679-86; viii. PubMed ID: 18992621
[TBL] [Abstract][Full Text] [Related]
3. Multi-modal treatment for metastatic renal cancer: the role of surgery.
Russo P
World J Urol; 2010 Jun; 28(3):295-301. PubMed ID: 20364382
[TBL] [Abstract][Full Text] [Related]
4. Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era.
You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
Jpn J Clin Oncol; 2015 Jan; 45(1):96-102. PubMed ID: 25341544
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
[TBL] [Abstract][Full Text] [Related]
6. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era.
Lyon TD; Thompson RH; Shah PH; Lohse CM; Boorjian SA; Costello BA; Cheville JC; Leibovich BC
J Urol; 2020 Feb; 203(2):275-282. PubMed ID: 31393812
[TBL] [Abstract][Full Text] [Related]
7. The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.
Choueiri TK; Xie W; Kollmannsberger C; North S; Knox JJ; Lampard JG; McDermott DF; Rini BI; Heng DY
J Urol; 2011 Jan; 185(1):60-6. PubMed ID: 21074201
[TBL] [Abstract][Full Text] [Related]
8. Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy.
Song Y; Du CX; Zhang W; Sun YK; Yang L; Cui CX; Chi YB; Shou JZ; Zhou AP; Li CL; Ma JH; Wang JW; Sun Y
Chin Med J (Engl); 2016 Mar; 129(5):530-5. PubMed ID: 26904986
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
[TBL] [Abstract][Full Text] [Related]
13. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.
You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579
[TBL] [Abstract][Full Text] [Related]
14. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
[TBL] [Abstract][Full Text] [Related]
15. Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.
De Gobbi A; Biasoni D; Catanzaro M; Nicolai N; Piva L; Stagni S; Torelli T; Procopio G; Verzoni E; Grassi P; Colecchia M; Paolini B; Spreafico C; Marchianò A; Salvioni R
Tumori; 2018 Oct; 104(5):388-393. PubMed ID: 28085177
[TBL] [Abstract][Full Text] [Related]
16. Nephrectomy in metastatic renal cell carcinoma.
Campbell SC; Flanigan RC; Clark JI
Curr Treat Options Oncol; 2003 Oct; 4(5):363-72. PubMed ID: 12941196
[TBL] [Abstract][Full Text] [Related]
17. How Did We Obtain Complete Remission in Patients Who Had Metastatic Renal Cancer in the Era of Targeted Therapies?
Brécheteau F; Lebdai S; Carrouget J; Lebigot J; Nedelcu C; Rousselet MC; Baize N; Azzouzi AR; Bigot P
Ann Surg Oncol; 2017 Feb; 24(2):369-374. PubMed ID: 27663564
[TBL] [Abstract][Full Text] [Related]
18. Contemporary experience with laparoscopic radical nephrectomy.
Mues AC; Haramis G; Rothberg MB; Okhunov Z; Casazza C; Landman J
J Laparoendosc Adv Surg Tech A; 2011; 21(1):15-8. PubMed ID: 21091214
[TBL] [Abstract][Full Text] [Related]
19. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
[TBL] [Abstract][Full Text] [Related]
20. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
